These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36972895)

  • 1. SI for NeuroAIDS: CNS function and dysfunction when HIV is a chronic disease.
    Smith BR; Nath A
    Neurosci Lett; 2023 May; 804():137203. PubMed ID: 36972895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.
    Nair M; Jayant RD; Kaushik A; Sagar V
    Adv Drug Deliv Rev; 2016 Aug; 103():202-217. PubMed ID: 26944096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of adult and pediatric NeuroAIDS.
    Mintz M
    Adv Neuroimmunol; 1994; 4(3):207-21. PubMed ID: 7874389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of HIV-associated disease of the central nervous system.
    Mallard J; Williams KC
    Handb Clin Neurol; 2018; 152():41-53. PubMed ID: 29604983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A SIV molecular clone that targets the CNS and induces neuroAIDS in rhesus macaques.
    Matsuda K; Riddick NE; Lee CA; Puryear SB; Wu F; Lafont BAP; Whitted S; Hirsch VM
    PLoS Pathog; 2017 Aug; 13(8):e1006538. PubMed ID: 28787449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1-associated central nervous system dysfunction.
    Krebs FC; Ross H; McAllister J; Wigdahl B
    Adv Pharmacol; 2000; 49():315-85. PubMed ID: 11013768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.
    Buckner CM; Luers AJ; Calderon TM; Eugenin EA; Berman JW
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):160-81. PubMed ID: 18040782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV dementia persists, but now it's a chronic disease.
    AIDS Alert; 2002 Apr; 17(4):46-8. PubMed ID: 12030200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS.
    Sagar V; Pilakka-Kanthikeel S; Martinez PC; Atluri VSR; Nair M
    PLoS One; 2017; 12(8):e0181642. PubMed ID: 28792504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS.
    Kumar S; Maurya VK; Dandu HR; Bhatt ML; Saxena SK
    Biomol Concepts; 2018 May; 9(1):33-42. PubMed ID: 29742062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NeuroAIDS in sub-Saharan Africa: a clinical review.
    Alkali NH; Bwala SA; Nyandaiti YW; Danesi MA
    Ann Afr Med; 2013; 12(1):1-10. PubMed ID: 23480988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Encephalopathy in AIDS--increased formation of beta-chemokines in monocytes after HIV-1 virus infection: mechanisms of CNS involvement].
    Mayer V; Schmidtmayerová H
    Bratisl Lek Listy; 1997 Jun; 98(6):330-4. PubMed ID: 9333424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When do models of NeuroAIDS faithfully imitate "the real thing"?
    Gelman BB; Endsley J; Kolson D
    J Neurovirol; 2018 Apr; 24(2):146-155. PubMed ID: 29256039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of neuroAIDS in Africa.
    Tadesse T; Langford D; Manji K; Mehari E
    J Neurovirol; 2005; 11 Suppl 1():22-6. PubMed ID: 15960237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions.
    Caniglia EC; Cain LE; Justice A; Tate J; Logan R; Sabin C; Winston A; van Sighem A; Miro JM; Podzamczer D; Olson A; Arribas JR; Moreno S; Meyer L; del Romero J; Dabis F; Bucher HC; Wandeler G; Vourli G; Skoutelis A; Lanoy E; Gasnault J; Costagliola D; Hernán MA;
    Neurology; 2014 Jul; 83(2):134-41. PubMed ID: 24907236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate drug use and the pathophysiology of neuroAIDS.
    Hauser KF; Fitting S; Dever SM; Podhaizer EM; Knapp PE
    Curr HIV Res; 2012 Jul; 10(5):435-52. PubMed ID: 22591368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory Effects of Nicotine on neuroHIV/neuroAIDS.
    Han H; Yang Z; Chang SL; Li MD
    J Neuroimmune Pharmacol; 2018 Dec; 13(4):467-478. PubMed ID: 30215204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [NeuroAIDS].
    Nakagawa M; Kondo M
    Nihon Rinsho; 2010 Mar; 68(3):502-7. PubMed ID: 20229798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NeuroAIDS in Africa.
    Robertson K; Liner J; Hakim J; Sankalé JL; Grant I; Letendre S; Clifford D; Diop AG; Jaye A; Kanmogne G; Njamnshi A; Langford TD; Weyessa TG; Wood C; Banda M; Hosseinipour M; Sacktor N; Nakasuja N; Bangirana P; Paul R; Joska J; Wong J; Boivin M; Holding P; Kammerer B; Van Rie A; Ive P; Nath A; Lawler K; Adebamowo C; Royal W; Joseph J;
    J Neurovirol; 2010 May; 16(3):189-202. PubMed ID: 20500018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second assessment of NeuroAIDS in Africa.
    Robertson K; Kopnisky K; Hakim J; Merry C; Nakasujja N; Hall C; Traore M; Sacktor N; Clifford D; Newton C; Van Rie A; Holding P; Clements J; Zink C; Mielk J; Hosseinipour M; Lalloo U; AMod F; Marra C; Evans S; Liner J;
    J Neurovirol; 2008 Apr; 14(2):87-101. PubMed ID: 18370346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.